| Affiliation: | 1. Experimental Therapeutics & Melanoma Service, Division of Hematology/Oncology, Columbia University Irving Medical Center, Milstein Hospital Building, 177 Fort Washington Avenue, 6GN-435, New York, NY 10032, USA;2. Division of Hematology/Oncology, Columbia University Irving Medical Center, Milstein Hospital Building, 177 Fort Washington Avenue, 6GN-435, New York, NY 10032, USA;1. Harvard T.H. Chan School of Public Health, Kresge Building Room 718, 677 Huntington Ave, Boston, MA 02115, USA;2. Department of Internal Medicine, East Carolina University/Vidant Medical Center, 600 Moye Boulevard, MA-350, Greenville, NC 27834, USA;3. Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Kresge Building, Room 718, 677 Huntington Avenue, Boston, MA 02115, USA;1. Oncology Center, Hospital Sírio Libanês, Rua Dona Adma Jafet, 91, São Paulo 01308-050, Brazil;2. Melanoma Service, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, 1275 York Avenue, New York, NY 10065, USA;1. Department of Dermatology, University Hospital Tübingen, Liebermeisterstr. 25, D-72076 Tübingen, Germany;2. Department of Radiooncology, University Hospital Tübingen, Hoppe-Seyler-Str. 3, D-72076 Tübingen, Germany;1. Hôpital Pitié-Salpêtrière, 47–83, boulevard de l’hôpital, 75013 Paris, France;2. Kremlin-Bicêtre, 31, rue du Général Leclerc, 94270 Kremlin-Bicêtre, France |
